Health
EBMT trial shows improvements in treatment of Severe Aplastic Anaemia – EurekAlert
The European Society for Blood and Marrow Transplantation (EBMT), Europe’s collaborative peer network of professionals working in the field of stem cell transplantation and cellular therapy, announced today the results of the phase III RACE trial during EBMTs…
The European Society for Blood and Marrow Transplantation (EBMT), Europe’s collaborative peer network of professionals working in the field of stem cell transplantation and cellular therapy, announced today the results of the phase III RACE trial during EBMTs virtual 46th Annual Meeting. Preliminary data show that adding Eltrombopag to standard immunosuppressive treatment is safe and increases response rates in patients with Severe Aplastic Anaemia (SAA).
SAA is a condition in which the bone m…
-
General20 hours agoTaylor Swift breaks Adele’s record for most album sales in first week
-
Noosa News22 hours agoNoosa Open Studios 2025 Art Trail kicks off today
-
Business23 hours agoWhat’s Macquarie’s price target on Mineral Resources shares?
-
Noosa News22 hours agoSpeeding offences, Peregian Springs – Sunshine Coast